Skip to: site menu | section menu | main content


|
|
|
|

14 - 17 January | 2007 | Cortina d'Ampezzo | Italy

LATEST NEWS: 04/1/07
Updated Travel Details


"A formal notification has been sent to all applicants to inform them of the results of the review - selected applicants will need to register by 20th December 2006 according to the instructions provided in the message of acceptance (e-mail and fax)
For any queries: lippolis@icgeb.org


Programme

 

 

 

 




Sunday, 14th January, 2007

15:00  
Arrival and Check-in
18:00       
Welcome Cocktail
18:30  
Juan Valcárcel

ICREA and Centre de Regulació Genòmica, Barcelona, Spain

Genetic programmes of Alternative Splicing regulation
19:00      
Adrian Krainer

Cold Spring Harbor Laboratory, NY, USA

Oncogenic properties of the splicing factor SF2ASF
19:30    
Mariano García Blanco

Duke University Medical Centre, Durham, NC, USA

Identification of the cellular targets of the transcription factor
CA150 (TCERG1) reveals a widespread role in mRNA processing
20:00  
Dinner
Monday, 15th January, 2007

09:oo   
Nicholas J. Proudfoot

Sir William Dunn School of Pathology, University of Oxford, UK

Interconnections between transcripton, RNA processing and gene structure in eukaryotes
09:30       
Alberto R. Kornblihtt

Laboratorio de Fisiología y Biología Molecular, FCEyN, Universidad de Buenos Aires, Argentina

Pol II elongation and factor recruitment in the coupling between transcription and alterntive splicing
10:00   
Christopher W. J. Smith

University of Cambridge, UK

Cross-regulation and functional redundancy between PTB and nPTB

10:30  
Javier F. Caceres

MRC Human Genetics Unit, Western General Hospital, Edinburgh, UK

Regulation of alternative splicing: Identification of RNA targets for SF2/ASF and hnRNP A1
11:00 
Coffee break
11:30
Reinhard Lührmann


Max-Planck Institute, Göttingen, Germany

Assembly and structural dynamics of the spliceosome
12:00       
Angela Kraemer

University of Geneva, Switzerland

Analysis of SF1 function in alternative splicing
   
12:30  
Lunch /free time
16:30
  Alex Watkins


AFFYMETRIX, UK Ltd., High Wycombe, UK
               
Analysis of Alternative Splicing Using Affymetrix High Density Microarrays

 

17:00
 
Jorgen Kjems


University of Aarhus, Denmark

A proximal 5’ splice site in HIV-1 stimulates transcriptional initiation
17:30
 
James Stévenin

INSERM, IGBMC, Illkirch, France

The human RBMY, a potential germline-specific splicing regulator with unique RNA recognition

18:00
 
Carlos Suñé

Instituto de Parasitología y Biomedicina Lopez Neyra, Granada, Spain

Connection between transcriptional elongation and splicing

18:15
 
Jean Beggs

University of Edinburgh, UK

Retinitis pigmentosa type 13 mutations affect the interaction of Prp8p with Brr2p and cause a defect in the maturation of U5 snRNPs in yeast

18:30
 
Break
19:00
 
Giuseppe Biamonti

Istituto di Genetica Molecolare – CNR, Pavia, Italy


Alternative splicing of the Ron proto-oncogene: a model system to study the link between regulation of alternative splicing and tumor progression


19:30
 
Francisco Baralle

International Centre for Genetic Engineering and Biotechnology, Trieste, Italy

Influence of the genomic context on splicing efficiency

20:00
 
Rossella Tupler

Universita’ di Modena e Reggio Emilia, Italy

Analysis of the role of FRG1 in FSHD pathogenesis

20:15
 
Dinner
21:30
 
Poster Session
   
Tuesday, 16th January, 2007



9:00   
 
Benoit Chabot

Université de Sherbrooke, Québec, Canada

Modern human introns: links with alternative splicing and diseases
09:30
 
Igor Vorechovsky

University of Southampton, UK

Disease gene variants that influence splicing efficiency of weak introns in the 5 leader sequences: lesson from IDDM2
09:45
 
Maria Carmo-Fonseca

Instituto de Medicina Molecular, Lisboa, Portugal

Splicing defects in oculopharyngeal muscular dystrophy
10:15
 
Jane Wu

Northwestern University, Chicago, IL, USA

Pre-mRNA splicing and Neurodegeneration
10:45
 
Jernej Ule

MRC Laboratory of Molecular Biology, Cambridge, UK

Insights from the RNA map of NOVA-dependent splicing regulations
11.00
 
Break
11:30   
 
Douglas L. Black

HHMI/UCLA, Los Angeles, CA, USA

Alternative Splicing and the Regulation of Neuronal Gene Expression
12:00 
 
Franco Pagani

International Centre for Genetic Engineering and Biotechnology, Trieste, Italy

Friedrech’s ataxia GAA non-coding repeats expansions affect pre-mRNA processing
12:30
 
Lunch / Free Time
17:00
 
Conxi Lázaro

Centre de Genètica Mèdica i Molecular, IRO-IDIBELL, Barcelona, Spain

Double genetic characterization (DNA mutation versus RNA effect) of mutations in the NF1 gene: what we have learned about disease-causing splicing mutations
17:30
 
Margarida D. Amaral

University of Lisboa, Portugal
Processing of mRNA in Cystic Fibrosis: Lessons from Native Tissues
18:00
 
Marquis Julien

University of Bern, Switzerland

 Complete splicing correction of SMN2 pre-mRNA by a bifunctional modified U7 snRNP
18:15
 
Geoff Woods

Addenbrookes Hospital, Cambridge, UK

Splice variants in important human neuro-developmental genes
18:45
 
Break
19:00
 
Diana Baralle

Addenbrookes Hospital, Cambridge, UK

 Can we make sense of genotype phenotype correlation?
19:30
 
Lia Crotti

University of Pavia, IRCCS Policlinico S. Matteo, Pavia, Italy

Genotype-phenotype correlation and pre-mRNA splicing defects in the Long QT syndrome
20:00
 
Eric White

University of Michigan Medical Center, Ann Arbor, MI, USA

The role of the EIIIA splice isoform of fibronectin in lung fibrosis
20:30
 
Dinner
21:30
 
Posert session
   
Wednesday 17th January

9:15
 
Christiane Branlant

Institute of Bioengineering, UMR 7567 CNRS UHP-Nancy I, Nancy, France

Implication of alternative splicing in viral diseases, regulation of HIV-1 RNA splicing
09:30
 
Massimo Caputi

Florida Atlantic University, Boca Raton, FL, USA

Control of HIV-1 mRNA processing
10:00
 
Jamal Tazi

Université Montpellier II, France

SR proteins in physiological and pathological splicing and as a target for therapy
10:30 
 
Irene Bozzoni

University of Rome “La Sapienza, Italy

Exon skipping for the cure of the Duchenne Muscular Dystrophy
11:00
 
Break
11:30
 
Stefan Stamm

University of Erlangen, Germany

Regulation of SMN2 splice site selection by Protein Phosphatase 1
12:00 
 
Albrecht Bindereif

Justus-Liebig-Universität Giessen, Germany

Genome wide regulation of mammalian splicing by CA-rich elements: a combined RNAi and microarray approach
12:30
 
End
Afternoon Session:
 
a EURASNET networking and integration round table open to all interested scientists.

atop




 



 

 

Back to top